Continuous glucose monitors like Dexcom's Stelo and Abbott's Lingo are small, wearable devices that track blood glucose ...

The Global MedTech Industry Outlook for 2025 aims to provide insights into the anticipated performance of the MedTech sectors ...

DexCom is a leader in the continuous glucose monitoring (CGM) market, or devices that help diabetes patients track their blood glucose levels. The company encountered some issues in 2024, including ...

Entering 2025, these battered stocks look pretty undesirable for investors right now. But all hope isn't, and shouldn't be, lost on these companies. Here's why these stocks could make comebacks this ...

Abbott and Dexcom have agreed to settle all of their remaining international legal disputes over patents related to their continuous glucose monitors for people with diabetes—just weeks after a ...

Abbott and Dexcom settled all patent lawsuits related to continuous glucose monitors (CGMs). The two competitors, who lead the U.S. market for CGMs, agreed on Dec. 20 to resolve all outstanding patent ...

DexCom and Abbott Reach Settlement in Global Patent Dispute. DexCom, Inc. (DXCM, Financial) has announced a significant development in its ongoing global patent litigation with Abbott Diabetes Care, ...

ESP32-based portable blood glucose visualisation device with e-ink display. Utilizes Dexcom API, BME280, and VCNL4040 sensors. Developed in C++ for low power, long battery life.

These sought-after qualities are acknowledged by employers, and a substantial number of our placement students at Surrey receive offers for graduate-level positions or pursue further studies. The ...

Check out the list of ASSESSMENT TOPICS. Option A: Complete the SFU FAN X99 course. (A grade of C is required.) Option B: Upgrade high school math courses via ...